Edgewise Therapeutics's total assets for Q3 2025 were $583.47M, a decrease of -4.87% from the previous quarter. EWTX total liabilities were $24.82M for the fiscal quarter, a 2.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.